Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
465 |
|
| Actual shortage: | 54 (12%) | |
| Anticipated shortage: | 27 (6%) | |
| Avoided shortage: | 8 (2%) | |
| Resolved: | 376 (81%) | |
Discontinuation Reports |
68 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 51 (75%) | |
| Reversed: | 10 (15%) | |
Late reports |
51 (10%) |
|
Overdue reports |
12 (14%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| LEVETIRACETAM | 500MG | TABLET | Resolved | 2023-07-18 | 2023-09-25 | 198904 |
| LEVETIRACETAM | 500MG | TABLET | Resolved | 2024-01-17 | 2024-04-11 | 216276 |
| LEVETIRACETAM | 750MG | TABLET | Resolved | 2017-11-28 | 2017-12-16 | 30910 |
| LEVETIRACETAM | 750MG | TABLET | Resolved | 2019-05-06 | 2019-06-28 | 83143 |
| LEVETIRACETAM | 750MG | TABLET | Resolved | 2023-07-18 | 2023-08-28 | 198907 |
| LEVETIRACETAM | 750MG | TABLET | Anticipated shortage | 2024-05-28 | 2024-05-28 | 229012 |
| METFORMIN | 500MG | TABLET | Resolved | 2023-08-29 | 2023-09-19 | 203144 |
| CITALOPRAM | 20MG | TABLET | Resolved | 2020-10-20 | 2020-10-30 | 126740 |
| PRAVASTATIN | 20MG | TABLET | Resolved | 2019-11-21 | 2020-02-04 | 99491 |
| PRAVASTATIN | 40MG | TABLET | Resolved | 2019-10-21 | 2020-02-19 | 96871 |
| TOPIRAMATE | 200MG | TABLET | Resolved | 2018-08-14 | 2018-08-28 | 58056 |
| RISPERIDONE | 0.25MG | TABLET | Resolved | 2024-03-25 | 2024-05-17 | 223270 |
| RISPERIDONE | 1MG | TABLET | Avoided shortage | 2017-10-18 | 2017-10-24 | 26182 |
| OXYCODONE/ACET | 325MG 5MG | TABLET | Resolved | 2018-03-13 | 2018-05-03 | 42756 |
| OXYCODONE/ACET | 325MG 5MG | TABLET | Resolved | 2019-11-29 | 2020-06-03 | 100035 |
| OXYCODONE/ACET | 325MG 5MG | TABLET | Resolved | 2020-03-26 | 2020-06-03 | 109425 |
| LISINOPRIL/HCTZ (TYPE Z) | 10MG 12.5MG | TABLET | Resolved | 2020-10-20 | 2020-11-19 | 126743 |
| CARVEDILOL | 6.25MG | TABLET | Resolved | 2024-01-30 | 2024-02-13 | 217832 |
| CARVEDILOL | 12.5MG | TABLET | Resolved | 2024-04-10 | 2024-04-23 | 224791 |
| VALSARTAN | 40MG | TABLET | Resolved | 2018-07-10 | 2020-02-29 | 55083 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DIVALPROEX | 125MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2389 |
| DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2396 |
| DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2402 |
| MORPHINE SR | 15MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2020-04-08 | 2020-06-13 | 111515 |
| MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-04-08 | 111518 |
| MORPHINE SR | 60MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-06-03 | 111521 |
| BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151302 |
| BUPROPION SR | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151307 |